Increased fecal ethanol and enriched ethanol-producing gut bacteria <i>Limosilactobacillus fermentum</i>, <i>Enterocloster bolteae</i>, <i>Mediterraneibacter gnavus</i> and <i>Streptococcus mutans</i> in nonalcoholic steatohepatitisOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study investigated whether gut bacteria that produce endogenous ethanol contribute to nonalcoholic steatohepatitis (NASH). Researchers measured fecal ethanol, glucose, total proteins, triglyceride and total cholesterol using high-performance liquid chromatography. They also characterized the gut microbiota using microbial culturomics and 16S rRNA metagenomics targeting the V3V4 hypervariable region to identify which viable bacteria and genetic signatures were enriched in NASH.
Who was studied?
The study compared fecal samples from 41 patients with NASH to 24 controls without the disease. This case-control design allowed direct comparison of biochemical parameters and microbial composition between diseased and healthy states. No further demographic details are given in the abstract.
What were the most important findings?
Fecal ethanol and glucose were significantly elevated in NASH patients compared to controls, while triglyceride, total cholesterol and total protein levels did not differ. Culturomics identified enrichment of the ethanol-producing bacteria Enterocloster bolteae and Limosilactobacillus fermentum in NASH samples. 16S rRNA sequencing confirmed enrichment of ethanol-producing bacteria including L. fermentum, corroborating the culture-based findings with independent genetic evidence.
What are the greatest implications of this study?
The findings support endogenous ethanol production by specific gut bacteria as a plausible mechanistic contributor to NASH, independent of dietary alcohol intake. By combining culturomics with 16S metagenomics, the study strengthens the case that microbially derived ethanol, rather than only enterobacteria or yeasts previously implicated, may drive liver injury in NASH. This suggests ethanol-producing bacteria such as L. fermentum and E. bolteae could become targets for diagnostic or therapeutic strategies aimed at reducing hepatic damage in NASH patients.